PLoS ONE · 2013 · 12 citations · 27 references
MedicineMolecular BiologyOncologyCarcinogenesisChemotherapyMolecular OncologyCellular Drug EffluxChemotherapy ResistanceMultidrug ResistanceNuclear TransportNuclear-cytoplasmic TransportTherapeutic ResistanceAnticancer Drug ResistanceMultidrug Efflux TransportersMultidrug Resistance TransportMultidrug Resistance-associated Protein-mediated EffluxOral Mucoepidermoid CarcinomaSpearman Rank Correlation CoefficientTransporter-mediated Drug ResistanceWestern Blot Analysis
BACKGROUND: Multidrug resistance-related protein 1 (MRP1/ABCC1) and multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1) are both membrane-bound drug transporters. In contrast to MDR1, MRP1 also transports glutathione (GSH) and drugs conjugated to GSH. Due to its extraordinary transport properties, MRP1/ABCC1 contributes to several physiological functions and pathophysiological incidents. We previously found that nuclear translocation of MRP1 contributes to multidrug-resistance (MDR) of mucoepidermoid carcinoma (MEC). The present study investigated how MRP1 contributes to MDR in the nuclei of MEC cells. METHODS: Western blot and RT-PCR was carried out to investigate the change of multidrug-resistance protein 1 (MDR1) in MC3/5FU cells after MRP1 was downregulated through RNA interference (RNAi). Immunohistochemistry (IHC) staining of 127 cases of MEC tissues was scored with the expression index (EI). The EI of MDR1 and MRP1 (or nuclear MRP1) was analyzed with Spearman's rank correlation analysis. Using multiple tumor tissue assays, the location of MRP1 in other tissues was checked by HIC. Luciferase reporter assays of MDR1 promoter was carried out to check the connection between MRP1 and MDR1 promoter. RESULTS: MRP1 downregulation led to a decreased MDR1 expression in MC3/5FU cells which was caused by decreased activity of MDR1 promoter. IHC study of 127 cases of MEC tissues demonstrated a strong positive correlation between nuclear MRP1 expression and MDR1 expression. Furthermore, IHC study of multiple tumor tissue array sections showed that although nuclear MRP1 widely existed in MEC tissues, it was not found in normal tissues or other tumor tissues. CONCLUSIONS: Our findings indicate that nuclear MRP1 contributes to MDR mainly through regulating MDR1 expression in MEC. And the unique location of MRP1 made it an available target in identifying MEC from other tumors.
27
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Susan P.C. Cole, Gabu Bhardwaj, James H. Gerlach et al. · Science · 1992 · 3.1K citations
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +17
Management and Outcome of Patients With Malignant Salivary Gland Tumors
R. Bryan Bell, Eric J. Dierks, L. D. Homer et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 277 citations
Medicine, Neck Surgery, Oncology +12
David N. Slack, Ole Morten Seternes, Mads Gabrielsen et al. · Journal of Biological Chemistry · 2001 · 270 citations · Full text